Phenotypeca engages grant writing specialist, Dr Emma Richardson, to lead a non-dilutive funding strategy at the end of August

August 2020

We are delighted to announce that Dr Emma Richardson has joined our team to support us to win grant funding from non-dilutive sources starting on 24th August.

Emma is a grant writing specialist who is highly proficient in innovation management and grant writing, having prepared over 100 funding applications for R&D firms in the Life Science, Medical Device, and Biotechnology sectors, from a range UK and EU funders. 

Grant funding is a significant income source for Phenotypeca’s platform development until it is ready for commercial launch in 2021.

Emma has a 1st Class Molecular Biology and Biochemistry BSc from Durham University, and a PhD in RNA Biology from the University of Nottingham.  She has spent the past seven years as a business consultant specialising in grant funding support for innovative companies of all sizes.